TCTR20210616003尚未招募不适用
Coronary Artery Disease Acute Coronary Syndrome Myocardial Infarction Percutaneous Coronary Intervention
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 2,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 N/A (No limit)（—）
- 性别
- All
入选标准
- •all patients undergoing percutaneous coronary intervention (PCI) at Maharaj Nakorn Chiang Mai Hospital.
排除标准
- •patient not undergoing percutaneous coronary intervention (PCI)
研究者
相似试验
已完成
3 期
The Australian COPS trial - COlchicine in Patients with acute coronary SyndromesIschaemic heart diseaseCardiovascular - Coronary heart diseaseACTRN12615000861550St. Vincent's Hospital Melbourne800
进行中（未招募）
不适用
Acute heart failure in acute coronary syndrome: Double blind comparison of levosimendan and placebo - LEVI´SAcute coronary syndrome treated with percutaneous coronary intervention (PCI)Patients suffering from acute heart failure after the procedure will be randomised to the studyMedDRA version: 9.1Level: LLTClassification code 10000803Term: Acute heart failureEUCTR2008-001637-10-FIHUCH, Division of Cardiology
招募中
不适用
Clinical Pathways for Acute Coronary Syndromes in China - phase 2: implementation and evaluatioAcute Coronary SyndromesCardiovascular - Coronary heart diseaseACTRN12609000491268Sanofi-Aventis (China)15,000
招募中
不适用
Atherosclerotic Complex coronary Artery Diseases treated by Zotarolimus-Eluting Resolute Onyx stent ~A multi-center registry~JPRN-UMIN000038451Toyohashi Heart Center800
招募中
不适用
Mie Acute Coronary Syndrome RegistryAcute Coronary SyndromeJPRN-UMIN000036020Mie University Hospital, CCU Network Center6,000